Pediatric viral threats surge in the 21st century: A call for One Health approach

Scoping review in “Pediatric Research” examines the rise of pediatric viral diseases in the 21st century and underscores the importance of a One Health approach, integrating human, animal, and ecosystem health, to combat these emerging and re-emerging infectious threats effectively.

Risk adjusted net present value: What is the current valuation of Cullinan Therapeutics’s CLN-619?

CLN-619 is a monoclonal antibody commercialized by Cullinan Therapeutics, with a leading Phase I program in Ovarian Cancer;Cervical Cancer;Endometrial Cancer.

December 14, 2024

Parakeet Health Launches With $3M for GenAI Voice Platform

Parakeet’s founding team Co-founder and CEO Jung Park, Co-founder Eric Mao, and CTO Aaron Lee What You Should Know: – Parakeet Health, a generative AI

October 16, 2024

Nurse-Supported Cognitive Behavioral Therapy for Insomnia Improved Sleep Outcomes

Nurse-supported, self-directed cognitive behavioral therapy (CBT) for insomnia reduced severity scores and improved sleep outcomes, a randomized trial of veterans showed. Among 178 veterans, Insomnia

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.